CEO AstraZeneca, Pascal Soriot, dalam acara Drug Pricing in America: A Prescription for Change, Part II di Washington DC, Amerika Serikat, 26 Februari 2019.(GETTY IMAGES/WIN MCNAMEE via AFP)